Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: magazinearticle
|
Bill's heart: the troubling story behind a historic experimentLife (Chicago), 1985-05, Vol.8 (5), p.33-42ISSN: 0024-3019 ;EISSN: 2169-1576 ;PMID: 11649640Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
Advances in the applications of monoclonal antibodies in clinical oncologyBritish journal of cancer, 1987-12, Vol.56 (4), p.509-530 [Peer Reviewed Journal]ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.1987.235Full text available |
|
3 |
Material Type: Article
|
Enfermedad experimental y enfermedad profesional por diisocianato de tolueno (DIT)Archivos de bronconeumología, 1988-03, Vol.24 (2), p.100-101 [Peer Reviewed Journal]1988 Sociedad Española de Neumología y Cirugía Torácica ;ISSN: 0300-2896 ;DOI: 10.1016/S0300-2896(15)31876-7Digital Resources/Online E-Resources |
|
4 |
Material Type: Article
|
Evaluation of intradermal test for diagnosis of fascioliasis in buffaloesBuffalo Bulletin, 1988-12, Vol.7 (4)ISSN: 0125-6726Digital Resources/Online E-Resources |
|
5 |
Material Type: magazinearticle
|
Will insurers pay for high-tech care? Many medical advances remain experimental, and thus aren't eligible for coverage, carriers argue. Doctors say patients are being denied lifesaving treatmentMedical economics, 1991-04, Vol.68 (8), p.82COPYRIGHT 1991 MJH Life Sciences Media ;COPYRIGHT 1991 UBM LLC ;ISSN: 0025-7206 ;EISSN: 2150-7155Digital Resources/Online E-Resources |
|
6 |
Material Type: magazinearticle
|
Passive Smoke: The EPA's Betrayal of Science and PolicyRegulation (Washington. 1977), 1999-01, Vol.22 (4), p.71Copyright Cato Institute 1999 ;ISSN: 0147-0590 ;EISSN: 1931-0668 ;CODEN: REGUD4Full text available |
|
7 |
Material Type: magazinearticle
|
What's NewPharmaceutical technology (2003), 2000-10, Vol.24 (10), p.203COPYRIGHT 2000 Intellisphere, LLC ;ISSN: 1543-2521 ;EISSN: 2150-7376Full text available |
|
8 |
Material Type: magazinearticle
|
What's NewPharmaceutical technology (2003), 2000-10, Vol.24 (10), p.203COPYRIGHT 2000 Intellisphere, LLC ;ISSN: 1543-2521 ;EISSN: 2150-7376Full text available |
|
9 |
Material Type: magazinearticle
|
What's NewPharmaceutical technology (2003), 2000-10, Vol.24 (10), p.203COPYRIGHT 2000 Intellisphere, LLC ;ISSN: 1543-2521 ;EISSN: 2150-7376Full text available |
|
10 |
Material Type: magazinearticle
|
What's NewPharmaceutical technology (2003), 2000-10, Vol.24 (10), p.203COPYRIGHT 2000 Intellisphere, LLC ;ISSN: 1543-2521 ;EISSN: 2150-7376Full text available |
|
11 |
Material Type: magazinearticle
|
A BIO-TERRORIST THREAT UNMASKEDThe Middle East (London, England : 1985), 2001-06 (313), p.18-18COPYRIGHT 2001 IC Publications Ltd. ;COPYRIGHT 2001 IC Publications Ltd. ;Copyright International Communications Jun 2001 ;ISSN: 0305-0734 ;EISSN: 2051-302X ;CODEN: MIEAD9Full text available |
|
12 |
Material Type: magazinearticle
|
From Capacity Providers to Performance LeadersPharmaceutical Technology North America, 2001-07, Vol.25 (7), p.129COPYRIGHT 2001 Intellisphere, LLC ;Copyright Advanstar Communications, Inc. Jul 2001 ;ISSN: 1543-2521 ;ISSN: 1534-2131 ;EISSN: 2150-7376Full text available |
|
13 |
Material Type: magazinearticle
|
Outsourcing outlook. (Contract Services)Pharmaceutical Technology North America, 2002-06, Vol.26 (6), p.82COPYRIGHT 2002 Intellisphere, LLC ;Copyright Advanstar Communications, Inc. Jun 2002 ;ISSN: 1543-2521 ;ISSN: 1534-2131 ;EISSN: 2150-7376Full text available |
|
14 |
Material Type: magazinearticle
|
Survey reflects growing maturity of CMC outsourcing: Pharmaceutical Technology and Bio/Pharmaceutical Outsourcing Report's 2002 survey found that pharmaceutical companies are embracing outsourcing as a strategic alternative to in-house operations and are practicing ways to enhance the performance of contract servicesPharmaceutical technology (2003), 2002-08, Vol.26 (8), p.S16COPYRIGHT 2002 Intellisphere, LLC ;ISSN: 1543-2521 ;EISSN: 2150-7376Full text available |
|
15 |
Material Type: magazinearticle
|
Take these genes and call me in the morning; shots of naked DNA are injecting new life into the promise of gene therapy. Alzheimer's vaccine, anyone? .(Biomedicine )Wired (San Francisco, Calif.), 2002-09, Vol.10 (9), p.90ISSN: 1059-1028 ;EISSN: 1078-3148Full text available |
|
16 |
Material Type: magazinearticle
|
Growing businesses. (Acquisitions)Pharmaceutical technology (2003), 2003-02, Vol.27 (2), p.96COPYRIGHT 2003 Intellisphere, LLC ;Copyright Advanstar Communications, Inc. Feb 2003 ;ISSN: 1543-2521 ;EISSN: 2150-7376Full text available |
|
17 |
Material Type: Review
|
Abate, Tom. The Biotech Investor: How To Profit from the Coming Boom in BiotechnologyLibrary Journal, 2003, Vol.128 (4)COPYRIGHT 2003 Library Journals, LLC ;COPYRIGHT 2003 A wholly owned subsidiary of Media Source, Inc. No redistribution permitted. ;ISSN: 0363-0277Full text available |
|
18 |
Material Type: Review
|
The Biotech Investor: How To Profit from the Coming Boom in BiotechnologyLibrary Journal, 2003, Vol.128 (4), p.100Copyright Cahners Business Information, a division of Reed Elsevier, Inc. Mar 1, 2003 ;ISSN: 0363-0277 ;CODEN: LIBJA7Full text available |
|
19 |
Material Type: magazinearticle
|
Medical research focuses on bioterrorism. (Security Beat)National defense (Washington), 2003-05, Vol.87 (594), p.8COPYRIGHT 2003 National Defense Industrial Association ;ISSN: 0092-1491 ;EISSN: 1943-3115Full text available |
|
20 |
Material Type: Article
|
Conferences.(listing of international conferences, 2003)Family matters (Melbourne, Vic.), 2003-09, p.90 [Peer Reviewed Journal]COPYRIGHT 2003 Australian Institute of Family Studies ;ISSN: 1030-2646Full text available |